Gayle Deflin, Director of Amphastar Pharmaceuticals AMPH, has filed 0 purchases and 3 sales on the open market. The latest trade was on 06/01.

GD

GD

Gayle Deflin

Director

Company

Amphastar Pharmaceuticals AMPH

First filing

23/05/19

Trades

11 trades

Buys / sales

0 / 3

12-month net buying

No record

Last trade

06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Amphastar PharmaceuticalsAMPH	Open-market sale	23/11/14	23/11/15	4,163 sh	$55.45	$230,838.35	−60.5%
Amphastar PharmaceuticalsAMPH	Open-market sale	23/05/18	23/05/19	4,519 sh	$44.01	$198,881.19	−52.1%
Amphastar PharmaceuticalsAMPH	Open-market sale	23/05/15	23/05/17	1,500 sh	$43.15	$64,725	−14.7%